Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus
Journal of Alzheimer’s Disease · 13.06.2023 · 93 (4) · 1341-1354
DOI: 10.3233/jad-221180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 06.05.2023. Verfasst von Fuxia Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Huadong Hospital Affiliated to Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Chitinases, Neurodegenerative Diseases, Alzheimer Disease, Hydrocephalus, Normal Pressure. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Neurodegenerative disease pathology is associated with neuroinflammation, but evidence on idiopathic normal pressure hydrocephalus (iNPH) remains limited and cerebrospinal fluid (CSF) biomarker profiles need to be elucidated.
Objective
To investigate whether iNPH pathological mechanisms are associated with greater CSF markers of core Alzheimer’s disease pathology (amyloid-β42 (Aβ 42 ), phosphorylated tau (P-tau)), neurodegeneration (total tau (T-tau)), and neuroinflammation (soluble triggering receptor expressed on myeloid cells 2 (sTREM2), chitinase-3-like protein 1 (YKL-40)).
Methods
The study analyzed lumbar CSF samples from 63 patients with iNPH and 20 age-matched orthopedic surgery patients who had no preoperative gait or cognitive impairment (control group). Aβ 42 , T-tau, P-tau, sTREM2, and YKL-40 in different subgroups were investigated.
Results
CSF sTREM2 levels were significantly higher in the iNPH group than in the control group, but no significant between-group difference was noted in YKL-40. Moreover, YKL-40 levels were significantly higher in the tap test non-responders than in the tap test responders ( p = 0.021). At the 1-year follow-up after shunt surgery, the CSF P-tau levels were significantly lower ( p = 0.020) in those with gait improvement and the CSF sTREM2 levels were significantly lower ( p = 0.041) in those with cognitive improvement. In subgroup analysis, CSF sTREM2 levels were strongly correlated with CSF YKL-40 in the iNPH group ( r = 0.443, p < 0.001), especially in the tap test non-responders ( r = 0.653, p = 0.002).
Conclusion
YKL-40 and sTREM2 are disease-specific markers of neuroinflammation, showing higher CSF levels in iNPH. In addition, sTREM2 is positively associated with YKL-40, indicating that interactions of glial cells play an important role in iNPH pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
- Department of Neurosurgery, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Zitieren
APA
Yang, F., Yang, L., Fang, X., Deng, Y., Mao, R., Yan, A., & Wei, W. (2023). Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus. Journal of Alzheimer’s Disease, 93(4), 1341-1354. https://doi.org/10.3233/jad-221180
Vancouver
Yang F, Yang L, Fang X, Deng Y, Mao R, Yan A, et al. Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus. Journal of Alzheimer’s Disease. 2023;93(4):1341-1354. doi:10.3233/jad-221180
BibTeX
@article{Yang2023,
author = {Yang, Fuxia and Yang, Lu and Fang, Xuhao and Deng, Yao and Mao, Renling and Yan, Aijuan and Wei, Wenshi},
title = {Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus},
journal = {Journal of Alzheimer’s Disease},
year = {2023},
volume = {93},
number = {4},
pages = {1341--1354},
doi = {10.3233/jad-221180}
}
EUVIMED